Similarly, treatment of chronic lymphocytic leukemia (CLL) cells with dexamethasone enhanced FAO by upregulating PPARα, leading to their resistance to dexamethasone [117]. Here, PPARA is linked to B-cell chronic lymphocytic leukemia.